237 related articles for article (PubMed ID: 29450641)
1. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
2. Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses.
Manna A; Kellett T; Aulakh S; Lewis-Tuffin LJ; Dutta N; Knutson K; Chini E; Pinilla-Ibarz J; Lamanna N; Manochakian R; Malavasi F; Sher T; Chanan-Khan AA; Ailawadhi S; Paulus A
Blood Adv; 2020 May; 4(10):2143-2157. PubMed ID: 32421811
[TBL] [Abstract][Full Text] [Related]
3. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
[TBL] [Abstract][Full Text] [Related]
4. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
6. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
[TBL] [Abstract][Full Text] [Related]
7. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
De Matteis S; Molinari C; Abbati G; Rossi T; Napolitano R; Ghetti M; Di Rorà AGL; Musuraca G; Lucchesi A; Rigolin GM; Cuneo A; Calistri D; Fattori PP; Bonafè M; Martinelli G
J Transl Med; 2018 Jun; 16(1):172. PubMed ID: 29925389
[TBL] [Abstract][Full Text] [Related]
9. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
Gowda A; Ramanunni A; Cheney C; Rozewski D; Kindsvogel W; Lehman A; Jarjoura D; Caligiuri M; Byrd JC; Muthusamy N
MAbs; 2010; 2(1):35-41. PubMed ID: 20081380
[TBL] [Abstract][Full Text] [Related]
11. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
12. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
[TBL] [Abstract][Full Text] [Related]
13. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
[TBL] [Abstract][Full Text] [Related]
14. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T cell/B cell interaction by B-CLL cells.
Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells.
Smallwood DT; Apollonio B; Willimott S; Lezina L; Alharthi A; Ambrose AR; De Rossi G; Ramsay AG; Wagner SD
Blood; 2016 Jul; 128(4):542-52. PubMed ID: 27118451
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Söderberg O; Christiansen I; Carlsson M; Nilsson K
Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
[TBL] [Abstract][Full Text] [Related]
18. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
19. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia.
Mpakou VE; Ioannidou HD; Konsta E; Vikentiou M; Spathis A; Kontsioti F; Kontos CK; Velentzas AD; Papageorgiou S; Vasilatou D; Gkontopoulos K; Glezou I; Stavroulaki G; Mpazani E; Kokkori S; Kyriakou E; Karakitsos P; Dimitriadis G; Pappa V
Leuk Res; 2017 Sep; 60():74-81. PubMed ID: 28759799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
